GlassScriptPhysician profile
Hitesh V Patel
NPI 1144200619
$3,665.04
in general payments reported to CMS, 2019-2025
36 companies · $1,107 in 2025
The $1,107 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $277 · 2020: $66.92 · 2021: $103 · 2022: $445 · 2023: $661 · 2024: $1,005 · 2025: $1,107.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,773.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,773.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $790.22 | 2023-2025 | Jot Dx, Thoratec Heartmate 3 Lvas Implant Kit, Confirm Rx |
| Amgen INC. | $410.20 | 2023-2025 | Repatha, Repatha |
| Novartis Pharmaceuticals Corporation | $221.44 | 2020-2025 | |
| Pfizer INC. | $201.49 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $197.00 | 2019-2025 | Camzyos, Eliquis |
| Novo Nordisk INC | $182.57 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $179.17 | 2019-2025 | Lifevest |
| Boston Scientific Corporation | $155.01 | 2020-2023 | |
| Edwards Lifesciences Corporation | $148.92 | 2023 | Edwards Sapien 3 Ultra Transcatheter Heart Valve, Sapien 3 Ultra Resilia |
| Medtronic, INC. | $147.28 | 2022-2025 | Symplicity G3 |
| Kestra Medical Technology Services, INC. | $125.90 | 2025 | Assure Wcd |
| Merck Sharp & Dohme LLC | $116.45 | 2022-2025 | Verquvo |
| Sanofi-Aventis U.S. LLC | $101.20 | 2024 | |
| Astellas Pharma US INC | $83.97 | 2024-2025 | Veozah |
| Daiichi Sankyo INC. | $67.47 | 2024 | Injectafer |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $63.02 | 2022-2023 | |
| Eisai INC. | $56.35 | 2022-2024 | |
| Inspire Medical Systems, INC. | $49.68 | 2024-2025 | Inspire |
| Lexicon Pharmaceuticals, INC. | $43.31 | 2023-2024 | Inpefa |
| Alnylam Pharmaceuticals INC. | $27.97 | 2025 | Amvuttra |
| Lundbeck LLC | $24.53 | 2019 | |
| Vivaquant INC, Dba Rhythm Express | $24.38 | 2025 | Rhythm Express |
| Vital Connect, INC | $23.91 | 2023 | Vitalpatch Rtm |
| Abiomed | $23.81 | 2024 | Impella |
| Medicomp INC | $22.38 | 2024 | Telepatch Cardiac Monitor |
| Amarin Pharma, INC. | $22.03 | 2022 | |
| Portola Pharmaceuticals, LLC | $21.75 | 2019 | |
| Biotronik INC. | $20.37 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $19.82 | 2023 | Opsumit, Uptravi |
| Bayer Healthcare Pharmaceuticals INC. | $17.35 | 2022 | |
| Esperion Therapeutics, INC. | $14.33 | 2022 | |
| Tactile Systems Technology INC | $13.98 | 2019 | |
| Cleerly, INC. | $13.15 | 2024 | Cleerly Ischemia, Cleerly Labs |
| United Therapeutics Corporation | $12.05 | 2019 | |
| Janssen Pharmaceuticals, INC | $11.66 | 2019 | |
| Medtronic Vascular, INC. | $10.92 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hitesh Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.